102 related articles for article (PubMed ID: 17980359)
21. Glycogen synthase kinase 3 phosphorylates hypoxia-inducible factor 1alpha and mediates its destabilization in a VHL-independent manner.
Flügel D; Görlach A; Michiels C; Kietzmann T
Mol Cell Biol; 2007 May; 27(9):3253-65. PubMed ID: 17325032
[TBL] [Abstract][Full Text] [Related]
22. Blockade of epidermal growth factor receptor/mammalian target of rapamycin pathway by Icariside II results in reduced cell proliferation of osteosarcoma cells.
Geng YD; Yang L; Zhang C; Kong LY
Food Chem Toxicol; 2014 Nov; 73():7-16. PubMed ID: 25119583
[TBL] [Abstract][Full Text] [Related]
23. Flavopiridol downregulates hypoxia-mediated hypoxia-inducible factor-1alpha expression in human glioma cells by a proteasome-independent pathway: implications for in vivo therapy.
Newcomb EW; Ali MA; Schnee T; Lan L; Lukyanov Y; Fowkes M; Miller DC; Zagzag D
Neuro Oncol; 2005 Jul; 7(3):225-35. PubMed ID: 16053697
[TBL] [Abstract][Full Text] [Related]
24. Magnolol suppresses hypoxia-induced angiogenesis via inhibition of HIF-1α/VEGF signaling pathway in human bladder cancer cells.
Chen MC; Lee CF; Huang WH; Chou TC
Biochem Pharmacol; 2013 May; 85(9):1278-87. PubMed ID: 23416116
[TBL] [Abstract][Full Text] [Related]
25. Inhibition of HIF-1 alpha and VEGF expression by the chemopreventive bioflavonoid apigenin is accompanied by Akt inhibition in human prostate carcinoma PC3-M cells.
Mirzoeva S; Kim ND; Chiu K; Franzen CA; Bergan RC; Pelling JC
Mol Carcinog; 2008 Sep; 47(9):686-700. PubMed ID: 18240292
[TBL] [Abstract][Full Text] [Related]
26. Antisense-thioredoxin inhibits angiogenesis via pVHL-mediated hypoxia-inducible factor-1alpha degradation.
Kim WJ; Cho H; Lee SW; Kim YJ; Kim KW
Int J Oncol; 2005 Apr; 26(4):1049-52. PubMed ID: 15754001
[TBL] [Abstract][Full Text] [Related]
27. Edaravone inhibits the expression of vascular endothelial growth factor in human astrocytes exposed to hypoxia.
Ishikawa A; Yoshida H; Metoki N; Toki T; Imaizumi T; Matsumiya T; Yamashita K; Taima K; Satoh K
Neurosci Res; 2007 Dec; 59(4):406-12. PubMed ID: 17889387
[TBL] [Abstract][Full Text] [Related]
28. Resveratrol abrogates the effects of hypoxia on cell proliferation, invasion and EMT in osteosarcoma cells through downregulation of the HIF-1α protein.
Sun Y; Wang H; Liu M; Lin F; Hua J
Mol Med Rep; 2015 Mar; 11(3):1975-81. PubMed ID: 25384583
[TBL] [Abstract][Full Text] [Related]
29. Hypoxia-regulated expression of attenuated diphtheria toxin A fused with hypoxia-inducible factor-1alpha oxygen-dependent degradation domain preferentially induces apoptosis of hypoxic cells in solid tumor.
Koshikawa N; Takenaga K
Cancer Res; 2005 Dec; 65(24):11622-30. PubMed ID: 16357173
[TBL] [Abstract][Full Text] [Related]
30. Signal pathway of hypoxia-inducible factor-1alpha phosphorylation and its interaction with von Hippel-Lindau tumor suppressor protein during ischemia in MiaPaCa-2 pancreatic cancer cells.
Kwon SJ; Song JJ; Lee YJ
Clin Cancer Res; 2005 Nov; 11(21):7607-13. PubMed ID: 16278378
[TBL] [Abstract][Full Text] [Related]
31. Regression of solid tumors by engineered overexpression of von Hippel-Lindau tumor suppressor protein and antisense hypoxia-inducible factor-1alpha.
Sun X; Kanwar JR; Leung E; Vale M; Krissansen GW
Gene Ther; 2003 Dec; 10(25):2081-9. PubMed ID: 14595381
[TBL] [Abstract][Full Text] [Related]
32. 2-Oxoglutarate downregulates expression of vascular endothelial growth factor and erythropoietin through decreasing hypoxia-inducible factor-1alpha and inhibits angiogenesis.
Matsumoto K; Imagawa S; Obara N; Suzuki N; Takahashi S; Nagasawa T; Yamamoto M
J Cell Physiol; 2006 Nov; 209(2):333-40. PubMed ID: 16883594
[TBL] [Abstract][Full Text] [Related]
33. 6-Mercaptopurine, an activator of Nur77, enhances transcriptional activity of HIF-1alpha resulting in new vessel formation.
Yoo YG; Na TY; Yang WK; Kim HJ; Lee IK; Kong G; Chung JH; Lee MO
Oncogene; 2007 May; 26(26):3823-34. PubMed ID: 17146432
[TBL] [Abstract][Full Text] [Related]
34. Histone deacetylase inhibitors induce VHL and ubiquitin-independent proteasomal degradation of hypoxia-inducible factor 1alpha.
Kong X; Lin Z; Liang D; Fath D; Sang N; Caro J
Mol Cell Biol; 2006 Mar; 26(6):2019-28. PubMed ID: 16507982
[TBL] [Abstract][Full Text] [Related]
35. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
[TBL] [Abstract][Full Text] [Related]
36. Inhibitor of DNA binding 1 activates vascular endothelial growth factor through enhancing the stability and activity of hypoxia-inducible factor-1alpha.
Kim HJ; Chung H; Yoo YG; Kim H; Lee JY; Lee MO; Kong G
Mol Cancer Res; 2007 Apr; 5(4):321-9. PubMed ID: 17426247
[TBL] [Abstract][Full Text] [Related]
37. Cisplatin and doxorubicin repress Vascular Endothelial Growth Factor expression and differentially down-regulate Hypoxia-inducible Factor I activity in human ovarian cancer cells.
Duyndam MC; van Berkel MP; Dorsman JC; Rockx DA; Pinedo HM; Boven E
Biochem Pharmacol; 2007 Jul; 74(2):191-201. PubMed ID: 17498666
[TBL] [Abstract][Full Text] [Related]
38. Role of enolase-1 in response to hypoxia in breast cancer: exploring the mechanisms of action.
Gao J; Zhao R; Xue Y; Niu Z; Cui K; Yu F; Zhang B; Li S
Oncol Rep; 2013 Apr; 29(4):1322-32. PubMed ID: 23381546
[TBL] [Abstract][Full Text] [Related]
39. Maslinic acid inhibits the metastatic capacity of DU145 human prostate cancer cells: possible mediation via hypoxia-inducible factor-1α signalling.
Park SY; Nho CW; Kwon DY; Kang YH; Lee KW; Park JH
Br J Nutr; 2013 Jan; 109(2):210-22. PubMed ID: 22716951
[TBL] [Abstract][Full Text] [Related]
40. HER2 (neu) signaling increases the rate of hypoxia-inducible factor 1alpha (HIF-1alpha) synthesis: novel mechanism for HIF-1-mediated vascular endothelial growth factor expression.
Laughner E; Taghavi P; Chiles K; Mahon PC; Semenza GL
Mol Cell Biol; 2001 Jun; 21(12):3995-4004. PubMed ID: 11359907
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]